Jie Du, Ph.d
President & CEO
United States of America
Dr. Jie Du is a seasoned pharmaceutical executive and entrepreneur. She is one of the founders at Frontage Laboratories, which started its operations in 2001. Frontage has since grown into a multi national contract research organization (CRO), serving pharmaceutical clients in North America and Asia. After exiting her holdings at Frontage, she has been active as an angel investor of life science start-ups. In 2009, Dr. Du founded JDP Therapeutics. She is leading JDP in becoming a significant player in pharmaceutical innovation and development. Dr. Du’s pharmaceutical experience extends 20 years at Abbott, Merck and URL Pharma. During her tenure of increasing responsibilities at these companies, she led activities in pharmaceutical product development, project management, legal/patent strategies, product portfolio management, clinical development, and regulatory areas. Dr. Du is a brilliant initiator on pharmaceutical strategies. Three of her patents (assigned to URL Pharma) were licensed to King/Pfizer. Prior to starting JDP Therapeutics, Dr. Du served as the Director of Scientific Affairs at URL Pharma, a specialty pharma company in Philadelphia. Mainly in charge of clinical studies, she was one of the key corporate members responsible for the company’s outstanding growth from ~$50 M annual sales to ~$600 M. Dr. Du’s endless creativity has made her a renowned inventor of many U.S. and international patents. Dr. Du earned her Ph.D. degree from School of Pharmacy at University of the Pacific in California.
pharmaceutical product development, project management, legal/patent strategies, product portfolio management, clinical development, and regulatory areas